IVERIC bio Inc. Stock
Your prediction
IVERIC bio Inc. Stock
Our community identified positive and negative aspects for IVERIC bio Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the IVERIC bio Inc. stock. On the other hand our users think that "Management" could be a problem in the future.
Pros and Cons of IVERIC bio Inc. in the next few years
Pros
?
S********** s********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of IVERIC bio Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| IVERIC bio Inc. | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | -0.790% | -1.575% | -6.015% | -19.355% | -24.699% | -54.545% | -83.333% |
| Celldex Therapeutics | 0.000% | 1.587% | -12.727% | -11.111% | -12.727% | -50.920% | -9.177% |
| Achieve Life Sciences Inc. | 0.720% | 2.332% | -25.793% | 9.006% | -5.135% | -29.716% | -71.230% |
Comments
IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ISEE provided by MarketBeat
IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ISEE provided by MarketBeat
IVERIC bio, Inc. (NASDAQ: ISEE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for ISEE provided by MarketBeat